Skip to main content
  • Early Data Show Promise for Biolimus-Coated Balloon in Small-Vessel Lesions

    A novel biolimus drug-coated balloon was shown to be safe and effective in patients with small-vessel coronary artery disease compared to plain balloon angioplasty, a new first-in-man (FIM) trial reports.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details